Chemotherapy of non-schizophrenic chronic deliria
Péron-Magnan, P.; Ginestet, D.
La Revue du Praticien 22(32): 4475-4483
1972
ISSN/ISBN: 0035-2640 PMID: 4677003 Document Number: 44774
Document emailed within 1 workday
Related Documents
Bralet, M.C.; Yon, V.; Loas, G.; Noisette, C. 2000: Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients L'Encephale 26(6): 32-41Féline, A. 1972: Chemotherapy in schizophrenic patients La Revue du Praticien 22(32): 4485-4499
Clark, M.L.; Huber, W.K.; Hill, D.; Wood, F.; Costiloe, J.P. 1975: Pimozide in chronic schizophrenic outpatients Diseases of the Nervous System 36(3): 137-141
Gallant, D.M.; Bishop, M.P. 1972: Quide vs. Mellaril in chronic schizophrenic patients Current Therapeutic Research 14(1): 10-16
Zlobina, G.P.; Brusov, O.S.; Morozova, M.A.; Beniashvili, A.G. 2009: Platelet peculiarities in chronic schizophrenic patients Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(10): 47-50
Gillin, J.C.; Kaplan, J.A.; Wyatt, R.J. 1976: Clinical effects of tryptophan in chronic schizophrenic patients Biological Psychiatry 11(5): 635-639
Wysokiński, A. 2017: Serum folate and homocysteine in chronic schizophrenic patients Psychiatria Danubina 29(1): 92
Bishop, M.P.; Gallant, D.M. 1970: Loxapine: a controlled evaluation in chronic schizophrenic patients Current Therapeutic Research 12(9): 594-597
Hanihara, T.; Amagai, I.; Hagimoto, H.; Makimoto, Y. 1997: Hypouricemia in chronic schizophrenic patients with polydipsia and hyponatremia Journal of Clinical Psychiatry 58(6): 256-260
Simhandl, C.; Rogan, M.; Lesch, O.M.; Musalek, M.; Strobl, R. 1984: Value of professional and self evaluation scales in chronic schizophrenic patients Der Nervenarzt 55(7): 371-377
Huang, C.Z.; Weng, C.Y.; Huang, H.L.; Young, S.S.; Chang, J.F.; Lee, G.H. 1989: A study of chronic schizophrenic patients on the attention tests Gaoxiong Yi Xue Ke Xue Za Zhi 5(9): 482-492
Ivezić, S.; Ljubimir, V.; Urlić, I. 2001: Therapist-patient relationship in treatment of chronic schizophrenic patients Medicinski Arhiv 55(1 Suppl 1: 39-46
Werapongset, W.; Chaisirikul, S.; Chrujiporn, W.; Visanuyothin, T.; Kessawai, D.; Charisilp, C.; Ratanachata, N.; Sanichwannakul, K.; Wangdee, P.; Bunditchate, A.; Ukranand, P. 1998: Efficacy and tolerability of risperidone in chronic schizophrenic Thai patients Journal of the Medical Association of Thailand 81(5): 324-328
Carman, J.S.; Bigelow, L.B.; Wyatt, R.J. 1981: Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients Journal of Clinical Psychiatry 42(3): 124-128
Tondlová, H. 1976: Psychotherapy of chronic schizophrenic patients with personality defect in ambulant conditions Ceskoslovenska Psychiatrie 72(1): 51-54
Roncoroni, D. 1984: Long-term therapy of chronic schizophrenic patients with haloperidol decanoate Psychiatrische Praxis 11(2): 56-58
Loas, G.; Noisette, C.; Legrand, A.; Boyer, P.; Delahousse, J. 1996: Clinical characteristics of chronic schizophrenic patients presenting with severe anhedonia L'Encephale 22(5): 351-358
Gallant, D.M.; Bishop, M.P. 1970: Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients Current Therapeutic Research 12(6): 387-389
Wirshing, W.C.; Marder, S.R.; Eckman, T.; Liberman, R.P.; Mintz, J. 1992: Acquisition and retention of skills training methods in chronic schizophrenic outpatients Psychopharmacology Bulletin 28(3): 241-245
Sterlin, C.; Augustin, E.; Ban, T.A.; Jarrold, L. 1971: Doxepin as adjuvant medication in the treatment of chronic schizophrenic patients: a comparative study Current Therapeutic Research 13(1): 50-52